[HTML][HTML] Giant cell arteritis: reviewing the advancing diagnostics and management
EJ Bilton, SP Mollan - Eye, 2023 - nature.com
Abstract Giant Cell Arteritis (GCA) is well known to be a critical ischaemic disease that
requires immediate medical recognition to initiate treatment and where one in five people …
requires immediate medical recognition to initiate treatment and where one in five people …
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study
AK Hemmig, M Aschwanden, S Seiler, CT Berger… - RMD open, 2023 - rmdopen.bmj.com
Objectives To characterise factors associated with permanent vision loss (PVL) and potential
reasons for the therapeutic delay contributing to PVL in giant cell arteritis (GCA). Methods …
reasons for the therapeutic delay contributing to PVL in giant cell arteritis (GCA). Methods …
Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study
N Mensch, AK Hemmig, M Aschwanden, S Imfeld… - RMD open, 2023 - rmdopen.bmj.com
Objectives We evaluated the feasibility of a rapid glucocorticoid tapering regimen to reduce
glucocorticoid exposure in patients with giant cell arteritis (GCA) treated with glucocorticoids …
glucocorticoid exposure in patients with giant cell arteritis (GCA) treated with glucocorticoids …
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score …
R Foré, E Liozon, S Dumonteil, T Sené, E Héron… - Joint Bone Spine, 2024 - Elsevier
Introduction Giant cell arteritis (GCA) is complicated in 10 to 20% of cases by permanent
visual ischemia (PVI). International guidelines advocate the use of intravenous pulse of …
visual ischemia (PVI). International guidelines advocate the use of intravenous pulse of …
Riesenzellarteriitis
T Ness, B Nölle - Klinische Monatsblätter für Augenheilkunde, 2024 - thieme-connect.com
Giant cell arteritis (GCA) is the most common primary vasculitis and is associated with
potential bilateral blindness. Neither clinical nor laboratory evidence is simple and …
potential bilateral blindness. Neither clinical nor laboratory evidence is simple and …
[PDF][PDF] Giant cell arteritis
EJ Bilton, SP Mollan - 2023 - core.ac.uk
Giant cell arteritis (GCA) is the most common form of vasculitis with a pooled incidence rate
of 10 per 100,000 people over the age of 50 years old [1]. The prevalence in England has …
of 10 per 100,000 people over the age of 50 years old [1]. The prevalence in England has …